Cargando…
Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder – RETRACTION
Autores principales: | Ikenouchi, Atsuko, Okamoto, Naomichi, Konno, Yusuke, Fujii, Rintaro, Fujino, Yoshihisa, Yoshimura, Reiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935939/ https://www.ncbi.nlm.nih.gov/pubmed/35282843 http://dx.doi.org/10.1192/bjo.2022.40 |
Ejemplares similares
-
Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder
por: Ikenouchi, Atsuko, et al.
Publicado: (2021) -
Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression
por: Yoshimura, Reiji, et al.
Publicado: (2021) -
Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and
treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022) -
Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder
por: Watanabe, Keita, et al.
Publicado: (2022) -
A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
por: Okamoto, Naomichi, et al.
Publicado: (2021)